.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Acute Myeloid Leukemia
Breast Cancer
CLL
CURE Ambassador Program
Kidney Cancer
Liver Cancer
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MPN
Myeloma
Ovarian Cancer
Publications
Skin Cancer

Cancer TypeSee All >

Bladder
Brain
Breast
Gastrointestinal
Gynecologic
Head & Neck
Lung
Lymphoma
Myeloma
Sarcoma
Skin

About CURE

Press Releases
Share Your Story
Write for CURE

About
Advertise
Contact
TargetedOnc.com
OncLive.com
CancerNetwork.com
Terms & Conditions
Privacy
Do Not Sell My Information

Evaluating Therapeutic Options in Chronic Lymphocytic Leukemia

EP. 1: What Testing is Done Alongside a Diagnosis of CLL?

December 27th 2018

EP. 2: Chronic Lymphocytic Leukemia: Selecting Initial Therapy

December 27th 2018

EP. 3: Understanding the Timing of Therapy in CLL

December 27th 2018

EP. 4: Relapsed CLL: Factors in Choosing Therapy

December 27th 2018

EP. 5: Impacting CLL Management With Lifestyle Modification

December 27th 2018

EP. 6: Moving the Paradigm of CLL Management Forward

December 27th 2018

EP. 7: Confirming a Diagnosis of CLL

December 27th 2018

EP. 8: Role of Watchful Waiting in CLL

December 27th 2018

EP. 9: Indications for Initiating Therapy in CLL

December 27th 2018

EP. 10: Tests Used to Inform Treatment Decisions in CLL

December 27th 2018

Latest News

FDA’s Approval of Keytruda-Based Regimen for Certain Stomach Cancer Subtypes ‘Really Exciting’ For Patients

Heart Failure May Increase Cancer Risk

Easing Worried Patients During Difficult Times Throughout Cancer Treatment

A Trail of Crumbs

View More Latest News